Navy SEAL's ibogaine experience highlights risks

Shawn Ryan, a former U.S. Navy SEAL and CIA contractor, recently discussed his experiences with ibogaine, a psychoactive substance, on The Diary of a CEO podcast. Ryan's story sheds light on the potential risks associated with using ibogaine for treating post-traumatic stress disorder (PTSD) and other mental health issues.

The adrenaline trap

Ryan, who now hosts The Shawn Ryan Show, described the challenges many veterans face when transitioning to civilian life. According to Ryan, the lack of adrenaline and purpose after leaving military service can lead to depression and a sense of emptiness. This struggle is not unique to veterans; it can affect anyone who relies on external validation, such as students or business professionals.

Psychedelic treatment and its dangers

Ryan turned to ibogaine, derived from a West African plant, seeking relief from his mental health struggles. While some studies, such as one published in Nature Medicine in 2024, have shown ibogaine's potential to reduce symptoms of PTSD, depression, and anxiety, the treatment carries significant risks. The study noted that ibogaine can affect heart rhythm, necessitating medical supervision. Despite its potential benefits, ibogaine remains a Schedule I drug in the U.S., though research is being funded in states like Texas.

Ryan's personal experience with ibogaine was unsettling. He described it as a terrifying encounter with dark spiritual forces, leaving him feeling oppressed rather than healed.

The cost of staying true

Ryan emphasized the importance of authenticity and warned against imitating others. He believes that personal growth requires letting go of superficial rewards, such as financial gain or social approval, that conflict with one's values.

Why it matters

Ryan's story highlights the complexities of using psychedelics like ibogaine for mental health treatment. While some veterans report positive outcomes, the risks and potential negative experiences, as described by Ryan, underscore the need for caution and further research.

Understanding these experiences is crucial as interest in psychedelic therapies grows, particularly for treating conditions like PTSD and depression.

Ryan's narrative serves as a reminder of the broader challenges faced by veterans and others seeking meaning and healing in their lives.